1. Home
  2. MORN vs KRYS Comparison

MORN vs KRYS Comparison

Compare MORN & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morningstar Inc.

MORN

Morningstar Inc.

HOLD

Current Price

$170.10

Market Cap

8.8B

Sector

Finance

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$299.77

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MORN
KRYS
Founded
1984
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.8B
7.8B
IPO Year
2004
2017

Fundamental Metrics

Financial Performance
Metric
MORN
KRYS
Price
$170.10
$299.77
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
11
Target Price
$256.50
$297.60
AVG Volume (30 Days)
512.2K
278.4K
Earning Date
04-29-2026
05-04-2026
Dividend Yield
1.07%
N/A
EPS Growth
3.38
128.00
EPS
2.73
1.83
Revenue
$2,445,500,000.00
$389,130,000.00
Revenue This Year
$9.14
$38.74
Revenue Next Year
$7.23
$32.53
P/E Ratio
$63.22
$160.11
Revenue Growth
7.49
33.94
52 Week Low
$149.08
$123.03
52 Week High
$316.71
$319.48

Technical Indicators

Market Signals
Indicator
MORN
KRYS
Relative Strength Index (RSI) 46.21 58.31
Support Level $162.56 $246.17
Resistance Level $190.99 N/A
Average True Range (ATR) 7.34 13.41
MACD -0.19 -0.35
Stochastic Oscillator 40.66 71.19

Price Performance

Historical Comparison
MORN
KRYS

About MORN Morningstar Inc.

Morningstar Inc is a provider of independent investment research to financial advisers, asset managers, and investors. The company focuses its operations on two core sectors: data and research. It offers data on investments such as mutual funds, stocks, exchange-traded funds, closed-end funds, separate accounts, and variable annuities. Further, the company tracks real-time market data of equity, derivative, currency exchanges, and other investments. In its research operation, Morningstar offers analyst research on passive and active mutual funds, alternative funds, and college saving plans. Morningstar's majority of the revenue is generated in the United States of America.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: